Skip to main content
. 2009 Oct 1;9(23):1–40.

Table 7: Summary of Study Characteristics: Model 1.

Study,
Design (N),
Country
Inclusion
Criteria
Intervention Group Setting Control Outcomes# Length of FU
(Freq. of FU)**
Study
Quality
Care
provider
Types of Interventions Delivered Method
of Care
Delivery
MODEL OF CARE: 1. At least a registered nurse, registered dietician and physician (primary care and/or specialist)
California Medi-Cal Diabetes Study Group, 2004 (14)

RCT (N = 335)

USA
T2DM (>1y duration), age ≥18 y, HbA1c ≥7.5% RN, RD, E, PCP, CDE
  • Diabetes education

  • Diet counselling

  • Pharmacotherapy management

  • Exercise advice or training

  • Promotion of self-care, behavioural modification or problem-solving skills

  • Integration of multidisciplinary team with primary care

  • Case management or care coordination

  • Smoking cessation counselling

  • Psychosocial counselling

  • Blood glucose self-monitoring

  • Program retention strategies

  • Program discharge plan

  • Foot care

  • Weight management

  • Prevention and management of retinopathy, nephropathy, hypertension, dyslipidemia & CVD

Clinic visits (Individual) Community outpatient clinics (n=3) Usual care (by PCP) Primary: HbA1c 36 months (every 6 months) High
Gaede, et al, 2001 (13)






RCT (N = 149)






Denmark
T2DM, age 45-65y RN, RD, MD
  • Diabetes education (structured program)

  • Diet counselling

  • Pharmacotherapy management

  • Exercise advice or training

  • Promotion of self-care, behavioural modification or problem-solving skills

  • Smoking cessation counselling

Clinic visits (Individual & Group) Hospital outpatient clinic Usual care (by PCP) †† HbA1c, total-and HDL-cholesterol, triglycerides, body weight, current smokers, daily dietary intake, exercise, use of glucose- or lipid-lowering drugs Mean: 3.8 years (every 3 months) Moderate
Groeneveld, et al, 2001 (16)





Cluster RCT N = 246 Netherlands
T2DM, age <76y, treated by a PCP dRN (CDE), RD, PCP
  • Diabetes education

  • Diet counselling

  • Pharmacotherapy management

  • Integration of multidisciplinary team with primary care

Clinic visits (Individual) Primary carepractices (n=15) Usual care (by PCP) †† HbA1c, FBG, lipids, BP, weight 12 months (every 3 months) Moderate
Johansen, et al, 2007 (15)





RCT N = 106





Norway
T2DM, age 18-75 y, Caucasian, ≥ 1 CV risk factor dRN, RD, D, Physio
  • Diabetes education (structured program)

  • Diet counselling

  • Pharmacotherapy management

  • Exercise advice or training

  • Remuneration for gymnasium membership

Clinic visits (Individual & Group) Hospital outpatient clinic Usual care (by PCP) †† HbA1c; BP; FBG; total, HDL and LDL cholesterol; triglycerides; microalbumin-uria; leisure-time activity; HRQoL 24 months (every 3 months) High
Maislos, et al, 2004 (12)



Cluster RCT N = 82



Israel
T2DM, poorly controlled HbA1c (≥10%) dRN (CDE), RD, D
  • Diabetes education (structured program)

  • Diet counselling

  • Pharmacotherapy management

  • Exercise advice or training

  • Promotion of self-care, behavioural modification or problem-solving skills

  • Integration of multidisciplinary team with primary care

  • Blood glucose self-monitoring

Clinic visits (Individual) Primary carepractices (n=2) Usual care (by PCP, RN) †† HbA1c, compliance in attending clinic 6 months (as needed) Low
*

RCT, randomized controlled trial

BP, blood pressure; CV, cardiovascular; HbA1c, glycosylated hemoglobin; mo, months; PCP, primary care physician; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; y, years

NA, not available (contacted study author; data unavailable); NR, not reported

§

CDE, certified diabetic educator; D, diabetologist; dRN, diabetes specialist nurse; E, endocrinologist; HCP, health care professional; MD, physician (unspecified specialty); PCP, primary care physician; Pharm, pharmacist; Physio, physiotherapist; RD, registered dietician; RN, registered nurse

PCP, primary care physician

MD, physician; PCP, primary care physician; Pharm, pharmacist; RN, nurse

#

blood pressure; FBG, fasting blood glucose; HDL, high-density lipoprotein; HRQoL, health-related quality of life; LDL, low-density lipoprotein cholesterol

**

FU, follow-up

††

No specification of primary or secondary outcomes